BioSpace News Archive

Array Bio’s Melanoma Drug Almost Doubles Survival in Patients Compared to Zelboraf

At the time of the planned analysis comparing COMBO450 to vemurafenib monotherapy, a preliminary analysis of OS in patients treated with 300 mg encorafenib alone daily, demonstrated a median OS of 23.5 months.

February 6, 2018

·

11 min read

Business

Henry Schein to Webcast Fourth Quarter and Full Year 2017 Conference Call on Tuesday, February 20, 2018 at 10:00 A.M. Et

The company will also provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time.

February 6, 2018

·

2 min read

Business

Kymera Therapeutics Appoints Industry Veteran Mark E. Nuttall, Ph.D., as Chief Business Officer

Dr. Nuttall joins Kymera from Sanofi Genzyme where he led business development and licensing for Immunology and Inflammation and Neuroscience.

February 6, 2018

·

3 min read

Business

BioGX BV and AxonLab AG Announce Distribution Partnership

The multi-year partnership, which began Jan. 1, 2018, represents a significant step in the United States-based company’s overseas growth, as many of BioGX’s products will now be available to a considerably broader customer base.

February 6, 2018

·

3 min read

Vyaire Medical Takes Out Revolutionary Medical Dev

Business

LimFlow Taps a New Chairman of the Board and Expands Senior Management Team

The company appointed Zachary Woodson as VP of regulatory affairs and quality, and Theo Mastrokostopoulos as VP of sales and market development.

February 6, 2018

·

4 min read

Business

Access Scientific Receives Innovative Technology Contract from Vizient, Inc. For POWERWAND Extended Dwell Catheters

The contract was based on a recommendation of POWERWAND EDC by hospital experts in this category who serve on one of Vizient’s member-led councils.

February 6, 2018

·

2 min read

Astellas and Universal Cells Ink $124M R&D Pact fo

Business

MannKind Names Lilly Exec as New CMO

He will be based out of MannKind’s Westlake Village, California headquarters.

February 6, 2018

·

4 min read

Drug Development

Pharma Two B Ltd. Release: First Patients Dosed in Phase III Multi-Center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson’s Disease

“This fundraising enables Pharma Two B to complete the Phase III and expand its pipeline.”

February 6, 2018

·

2 min read

FDA

Grifols HyperRAB (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection

The most common adverse reactions during clinical trials were injection-site pain and headache.

February 6, 2018

·

8 min read

Pharm Country

Oticon Opn Hearing Aids Now Offer Hands-Free Convenience with ConnectClip

Today Oticon introduced the ConnectClip, a discreet, lightweight intermediary device that extends the convenience and performance of its Internet-connected Opn hearing aids.

February 6, 2018

·

3 min read